0001019687-13-003917.txt : 20131017
0001019687-13-003917.hdr.sgml : 20131017
20131017202822
ACCESSION NUMBER: 0001019687-13-003917
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131015
FILED AS OF DATE: 20131017
DATE AS OF CHANGE: 20131017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 14282 FRANKLIN AVE
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 7145086000
MAIL ADDRESS:
STREET 1: 14282 FRANKLIN AVE
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KING STEVEN W
CENTRAL INDEX KEY: 0001244106
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32839
FILM NUMBER: 131158049
4
1
king_f4.xml
FORM 4
X0306
4
2013-10-15
0
0000704562
PEREGRINE PHARMACEUTICALS INC
PPHM
0001244106
KING STEVEN W
14282 FRANKLIN AVE.
TUSTIN
CA
92780
1
1
0
0
President & CEO
Common Stock, $.001 par value
2013-10-15
4
A
0
100000
A
187403
D
Stock Option (right to buy)
0.46
2013-10-15
4
D
0
250000
D
2022-05-04
Common Stock
250000
1683500
D
Stock Option (right to buy)
1.39
2013-10-15
4
A
0
250000
A
2023-10-15
Common Stock
250000
1933500
D
On October 15, 2013, pursuant to a written mutual agreement between the issuer and the reporting person, the issuer canceled an option for 250,000 shares of common stock granted to the reporting person on May 4, 2012. In partial consideration for the cancellation of the option, the reporting person received 100,000 shares of common stock.
Represents the portion of a stock option grant that was originally granted to the reporting person on May 4, 2012 and was surrendered and cancelled pursuant to the terms of an agreement, dated October 15, 2013, by and between the reporting person and the issuer. Pursuant to the agreement and in consideration for the surrender and cancellation of the stock option grant, the reporting person received (1) 100,000 shares of common stock ("Stock Award"), (2) an option to purchase 250,000 shares of common stock, having an exercise price of $1.39 per share and (3) $83,685 in cash to cover applicable statutory state and federal income and employment taxes based on the statutory withholding rates resulting from the Stock Award.
On October 15, 2013, pursuant to a written mutual agreement between the issuer and the reporting person, the issuer canceled an option for 250,000 shares of common stock granted to the reporting person on May 4, 2012. In partial consideration for the cancellation of the option, the reporting person received a replacement option for 250,000 shares, having an exercise price of $1.39 a share.
The cancelled option provided for vesting in eight (8) equal quarterly installments over a two (2) year period beginning August 4, 2012 and each quarter thereafter until fully-vested.
The vesting terms of the new option grant are identical to the vesting schedule of the cancelled option grant, whereby, 156,250 options vest immediately as the reporting person received credit for the time elapsed since the original option grant, and the remaining 93,750 unvested options shall vest in three (3) equal quarterly installments beginning November 4, 2013 and each quarter thereafter until fully-vested.
/s/ Steven W. King
2013-10-17